BofA/Merrill Lynch downgraded Itron (NASDAQ: ITRI) from Buy to Underperform with a price target of $39.00 (from $40.00).Analyst Andrew Hughes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE